Navigation Links
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
Date:5/4/2009

SYDNEY, Australia, May 4 /PRNewswire-Asia-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) is pleased to announce positive results of its recently completed international Phase III trial of Bronchitol(TM) in people with cystic fibrosis. The study represents one of the largest clinical trials conducted in cystic fibrosis.

The primary endpoint of the trial was to assess whether Bronchitol improves lung function as measured by a change in Forced Expiratory Volume in 1 second (FEV1) when administered 400 mg twice per day for six months. The clinical trial comfortably met this endpoint. Patients treated with Bronchitol had a statistically significant improvement in lung function from baseline of 6.6% (p=0.001 versus placebo). Lung function improved at week 6 and was sustained through to week 26.

The key secondary endpoint of the trial was to assess whether Bronchitol further improves lung function in patients already being treated with the most commonly used CF therapeutic, dornase alfa (Pulmozyme(TM)). This endpoint was also successfully achieved. For patients being treated with concurrent dornase alfa, FEV1 improved after 6 months by 5.2% from baseline (p=0.002 versus placebo).

Over the 6 month treatment period, there was significant lung function improvement for both those patients being treated with Bronchitol and dornase alfa (p=0.008 versus placebo) and those being treated with Bronchitol alone (p=0.015 versus placebo).

Consistent loss of lung function, is the leading cause of death for people with cystic fibrosis and this deterioration now averages 1-2% per year.

Dr Alan Robertson, Pharmaxis Chief Executive Officer said: "We are delighted that Bronchitol performed so well in this important long term study and we now know that it can change th
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
2. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
3. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
4. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
5. Pharmaxis Establishes Named Patient Program for Bronchitol
6. Pharmaxis Long-Term Safety Study of Bronchitol Completes
7. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
8. Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
9. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
10. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
11. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Z-Medica, a ... it has launched the first-ever line of products designed ... The line includes QuikClot ® EMS 4x4 Dressing, ... ® EMS Rolled Gauze™, all custom-designed to help ... they can be transported to a hospital or trauma ...
(Date:5/22/2013)... MANALAPAN, N.J. , May 22, 2013 ... this opportunity to update shareholders about some recent company ... will expand its avenues of communication with shareholders. Integrating ... has launched a Facebook page and will post updates ... the Twitter hashtag is #medifirstusa. Says ...
(Date:5/22/2013)... Mass. , May 22, 2013  Flagship ... firm focused on healthcare and sustainability, today announced ... as a Senior Partner. In this role, ... to portfolio companies. In addition to ... Mr. Bancel also serves as President and Chief ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... 8 Transgenomic, Inc. (OTC Bulletin Board: TBIO). The ... mutation detection technology called Cold-PCR from the Dana-Farber Cancer ... standard PCR technology enriches mutations in DNA samples and ... level mutations in tissue and body fluids that are ...
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today the pricing ... stock at a price of $13.29 per share. After ... to receive net proceeds of approximately $52.9 million. All ... addition, Savient has granted the underwriters a 30-day option to ...
Cached Medicine Technology:Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute 2Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute 3Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute 4Savient Pharmaceuticals Prices Underwritten Offering of Common Stock 2
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Migraines and depression ... new research indicates the combination of the two may ... brain. , , Already aware that people with migraines ... determine if having both conditions together affected total brain ... -- isn,t alarming, study authors said, but needs further ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 Phelps ... established the Westchester Lung Nodule Center for individuals ... receive lung cancer care. Lung cancer is the deadliest form ... more people in the U.S. die from lung cancer than ... with all cancers, early detection increases survival rates. It ...
(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science Nathalie ... a recipe for making energy bars at home. , The ... takes a recipe modified from one recently featured on ... it gets more and more difficult to understand what ingredients ... of the nutrition label continues to grow and consumers are ...
(Date:5/22/2013)... Georgia (PRWEB) May 22, 2013 HR ... event, hosted at the Gwinnett County Fairgrounds, on Friday ... company before, they far surpassed expectations; raising over $6,300 ... corporate sponsor for the event, donating the first $3,000 ... Beesley , challenged the internal staff to match the ...
(Date:5/22/2013)... 2013 Go Classy the Original Nudist ... launch of their newest website http://www.Desire-Mexico.com . The ... minds, Desire Resorts have become the premier Nudist and ... of total liberation while allowing you to enjoy a ... Go Classy Tours / Caribbean-Hideaways. He goes on to ...
Breaking Medicine News(10 mins):Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:How To "Make Your Own Healthy Energy Bars" 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:Go Classy Tours Announces the Launch of Their Newest Website for Desire Resorts Located in Mexico Clothing Optional/Aunaturel Resorts a Lovers Paradise 2
... 26 Nutrisystem, Inc. (Nasdaq: NTRI ), a ... announced a new multi-year alliance with the American Diabetes ... and the public about the importance of weight loss ... the relationship, Nutrisystem will support the Association,s efforts to ...
... WASHINGTON , Oct. 26 America,s ... Ignagni, President and CEO: , "A new government-run plan would underpay ... costs and improve quality. The American people want health care ... , "The divisive debate about a government-run plan is ...
... of severe physical, psychosocial suffering, researchers say , MONDAY, ... World War II, those who were potentially exposed to ... due to physical and mental stress, an Israeli study ... rates in more than 300,000 Israeli Jews who were ...
... But healthy habits can stave off the inevitable declines, research ... in fitness that accompany growing old typically speed up after ... But people can slow the inevitable by staying lean, exercising ... Oct. 26 issue of the Archives of Internal Medicine ...
... doubled risk of GERD, may be linked to mental fallout ... rescue workers can add another illness to the list of ... Zero toxins and the ensuing mental anguish of the tragedy ... shows that 41 percent of World Trade Center responders have ...
... , PLANO, Texas, Oct. 26 Perot Systems Corporation (NYSE: ... an agreement with China Telecommunications Corporation (China Telecom) in which ... information technology (IT) solutions for the healthcare industry in China. ... to develop and go to market with an e-health platform ...
Cached Medicine News:Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 2Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 3Health News:AHIP Statement on Government-Run Plan 2Health News:AHIP Statement on Government-Run Plan 3Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Fitness Fades Fast After 45 2Health News:Fitness Fades Fast After 45 3Health News:World Trade Center Workers Have More Cases of Acid Reflux 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 3Health News:Perot Systems Announces Strategic Alliance With China Telecom 2Health News:Perot Systems Announces Strategic Alliance With China Telecom 3
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... ASRs* are specifically designed for PCR ... two-color fluorescence detection systems. The NGEN ... detection of mutations associated with cystic ... well as reagents for the detection ...
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
Medicine Products: